Oncology News & Articles

1 Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial The Lancet, May 22, 2012    Clinical Article

2 Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial The Lancet, May 22, 2012    Clinical Article

3 Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial The Lancet, May 22, 2012    Clinical Article

4 SSBP2 variants are associated with survival in glioblastoma patients Clinical Cancer Research, May 22, 2012

5 Adjuvant chemotherapy and risk of gastrointestinal, hematologic, and cardiac toxicities in elderly patients with stage III colon cancer American Journal of Clinical Oncology, May 22, 2012    Clinical Article

6 Activity of thalidomide and capecitabine in patients with advanced hepatocellular carcinoma American Journal of Clinical Oncology, May 22, 2012

7 Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis American Journal of Clinical Oncology, May 22, 2012

8 Meat and fish consumption and risk of pancreatic cancer--results from the European prospective investigation into cancer and nutrition International Journal of Cancer, May 22, 2012

9 Sequential chemoradiotherapy with gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma International Journal of Cancer, May 22, 2012

10 Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis International Journal of Cancer, May 22, 2012    Review Article

11 Phase 1 dose- escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias British Journal of Haematology, May 22, 2012

12 Real-world Impact of Availability of Adjuvant Therapy on Outcomes in Patients With Resected Pancreatic Adenocarcinoma American Journal of Clinical Oncology, May 22, 2012

13 Integrating Radioembolization With Chemotherapy in the Treatment Paradigm for Unresectable Colorectal Liver Metastases American Journal of Clinical Oncology, May 22, 2012

14 Screening Colonoscopy Among Colorectal Cancer Survivors Insured by Medicaid American Journal of Clinical Oncology, May 22, 2012

15 Is There a Clinical Benefit to Adaptive Planning During Tomotherapy in Patients with Head and Neck Cancer at Risk for Xerostomia American Journal of Clinical Oncology, May 22, 2012

16 Pseudoprogression in Patients With Glioblastoma Multiforme After Concurrent Radiotherapy and Temozolomide American Journal of Clinical Oncology, May 22, 2012    Clinical Article

17 Monitoring and evaluation tools for irinotecan and bevacizumab in glioblastoma Bulletin du Cancer, May 22, 2012    Clinical Article

18 Impact of late treatment-related radiotherapy toxicity, depression, and anxiety on quality of life in long-term breast cancer survivors Bulletin du Cancer, May 22, 2012

19 Polymorphisms of Base-Excision Repair Genes hOGG1 326cys and XRCC1 280His Increase Hepatocellular Carcinoma Risk Digestive Diseases and Sciences, May 22, 2012

20 Therapy options and long-term results of sinonasal malignancies Oral Oncology , May 22, 2012

Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies Journal of Thoracic Disease, 08/05/2011

1 Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP Protocol B-24 Journal of Clinical Oncology, April 9, 2012

2 The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal Journal of Gastrointestinal Oncology, April 16, 2012    Free full text

3 Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: Results of the randomized phase III CHER-LB study Journal of Clinical Oncology, April 12, 2012

4 Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer European Journal of Cancer, April 2, 2012

5 Metformin use is associated with better survival of diabetic patients with pancreatic cancer Clinical Cancer Research, April 4, 2012

6 Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study The Lancet, April 24, 2012

7 Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials The Lancet Oncology - Online First, March 22, 2012

8 Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data Journal of Clinical Oncology, April 5, 2012

9 Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer Cancer, April 6, 2012

10 Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial The Lancet Oncology - Online First, March 28, 2012

11 Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial The Lancet - Early Online Publication, April 5, 2012

12 The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus International Journal of Cancer, April 26, 2012

13 Infectious complications of chemotherapy in clinically aggressive mature B and T cell lymphomas European Journal of Internal Medicine , April 3, 2012

14 Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer JAMA, April 19, 2012

15 Association between tamoxifen treatment and diabetes Cancer, April 16, 2012

16 The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer International Journal of Cancer, April 23, 2012

17 Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings and correlation with clinical outcome European Journal of Cancer, April 11, 2012

18 Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix International Journal of Cancer, April 18, 2012

19 Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial The Lancet Oncology - Online First, April 20, 2012

20 Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C) Journal of Clinical Oncology, April 9, 2012